AMIS (Anterior Minimally Invasive Surgery)
is a hip replacement technique that follows both an intermuscular and internervous path to greatly decrease damage to periarticular structures while preserving tissue and which is supported by the industry’s most detailed surgeon training protocol.
“The promotion of patient well-being through AMIS is a cornerstone of Medacta’s mission, as it exemplifies our belief that only with a strong focus on medical education can surgical innovation truly move the industry forward,
” said Francesco Siccardi, Executive Vice President of Medacta International. “The patient-centric technique is also ideal for the outpatient or same-day surgery settings, providing more options for both surgeons and patients in today’s changing healthcare landscape.
Today, the AMIS technique
evolved into the concept of the AMIS Experience
, as it is much more than just a surgical technique, it is a complete set of services which provides for healthcare efficiency supportive of economic and commercial advantages for the hospital & surgeon.
Within the AMIS Experience it is possible to take advantage of:
is an evolution of the anterior approach: simpler, more reproducible and less invasive.
: The M.O.R.E. AMIS Education Program
is a tested and proven method of top level continuous education which effectively helps to smooth the learning curve.
DEDICATED IMPLANTS: Specifically developed to make their implantation easier through the anterior approach, supported by clinical evidence and customer success
AMIStem-H and QUADRA-H have been awarded the 7A rating by the ODEP Panel
AMIStem-H: 98.9% survival rate (Kaplan-Meier method) including any reason for revision as endpoint, at minimum 5 years follow-up
QUADRA-H: ONLY 1 revision for aseptic loosening out of 283 cases (survival rate of 99.65% with aseptic loosening as endpoint), at a minimum follow-up of 10 years
Versafitcup CC Trio: 98.6% survival rate including any reason for revision as endpoint, at minimum 10 years follow-up
: Developed specifically to make the AMIS technique
an easier and more reproducible procedure.
TOOLS AND SERVICES: Extras provided by Medacta to further support a surgeon’s practice.
MORE THAN 100 PUBLICATIONS AS CLINICAL EVIDENCE
 Kalberer F, Krupp F, Molnar V, Schmied-Steinbach A, Schläppi M. AMIStem-H: Radiological results at 5 years. M.O.R.E. Journal Supplement, July 2016
 Rahm S, Tondelli T, Steinmetz S, Schenk P, Dora C, Zingg P. Versafit Cup and Quadra Stem in THA Through the Direct Anterior Approach: Analysis of a Consecutive Series of 283 Hips with a Minimum Follow-up of 10 years. Podium presentation at the 78th Annual Congress of the Swiss Orthopaedics Jahreskongress, Montreux, Switzerland, June 6-8, 2018
 AMIS Publication Review – M.O.R.E. Journal Supplement, April 2016. 99.98.publ rev.01